reference preparations to permit interconversion and thus valid comparisons of results. The absence of an international reference preparation for prealbuinin, however, makes such comparisons problematic or at least much more difficult.
We hope that the efforts of the IFCC 
AntI-Aslaloglycoproteln Receptor

AntIbody and intestinal-Origin AlkalIne Phosphatase In Plasma In Diabetes
To the Editor:
Intestinal-origin alkaline phosphatase [orthophosphoric-monoester phosphohydrolase (alkaline optimum), EC 3.1.3.1; ALP] inplasma is an asialoglycoprotein, thought to be cleared at the asialoglycoprotein receptor at the liver cell surface. Hepatocyte damage with impaired enzyme uptake by the receptor is considered to account forthe increasedintestinal-origin ALP observed in plasma in liverdisease, particularly in cirrhosis (1). Increasedintestinal-originALP activity alsooccursin plasma in diabetes mellitus in the absence of obvious liver disorder, and no satisfactory explanation for the increase has been forthcoming. Circulating auto-antibodies to the hepaticasialoglycoprotein receptor(ASGP-R) have been observed in liver disease (2) . We wondered whether anti-ASGP-R auto-antibodies might be present in diabetes also, might interfere with enzyme uptake, and might be relevantto the increased intestinal-origin ALP in plasma.
We, therefore,examined plasma samples from 17 diabetics, all of blood group 0 and mainly of maturity-onset type. Liver-function test results were available for 14 subjects and were normal, except for minor increases in aspartate aminotransferase (61 U/L, We conclude that although anti-ASGP-R antibodies may be detectable in plasma in some patients with diabetes, they do not correlate with the concentration ofintestinal-origin ALP activity and cannot account for the increasedactivity of this enzyme.
We thank Dr. P. Dandona for providing plasma samples from patients in his care. 
T. Kuwana
Measurement of Glucose In Cerebrospinai Fluid with Reagent Strips and a Reflectance Photometer
To the Editor:
Measurement of glucose in blood and plasma by using reagent strips and reflectance photometry has become well established, and is widely available in both rural and general practice. However, little has been published on using these reagent strips and reflectance meters to measure glucosein cerebrospinal fluid (CSF).
